Related Experiment Video
Updated: May 20, 2025

09:35
Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
Published on: March 2, 2017
11.9K
Non-viable embryos created with synthetic DNA
Adrian Villalba1, Anna Smajdor2, Iain Brassington3
1Institut Cochin, CNRS, INSERM, Université Paris Cité, Paris, France; Department of Philosophy II, University of Granada, Granada, Spain.
Trends in Biotechnology
|March 25, 2025
Summary
Synthetic DNA (synDNA) technology may allow the creation of non-viable embryos for research. This approach could potentially bypass ethical concerns associated with traditional embryo experimentation.
Area of Science:
- Biotechnology
- Bioethics
- Developmental Biology
Background:
- Embryo research faces significant ethical objections.
- Synthetic DNA (synDNA) technology offers novel possibilities in biological research.
- Current research limitations hinder the study of early human development.
Purpose of the Study:
- To explore the potential of synthetic DNA (synDNA) technology for creating non-viable research embryos.
- To assess how synDNA technology might mitigate ethical concerns in embryo research.
- To identify the remaining challenges and future directions for synDNA applications in developmental biology.
Main Methods:
- Conceptual analysis of synDNA technology's application in embryo creation.
- Review of ethical frameworks concerning embryo research.
- Identification of technical and biological hurdles in synDNA-based embryo development.
Main Results:
- SynDNA could theoretically enable the construction of embryos incapable of development.
- This approach may circumvent ethical objections related to embryo viability and destruction.
- Significant scientific and technical challenges must be overcome for practical implementation.
Conclusions:
- Synthetic DNA technology presents a potential pathway to ethically explore early human development.
- Further research is needed to validate the feasibility and safety of synDNA-derived embryos.
- Careful consideration of bioethical implications is crucial as the technology advances.
Related Concept Videos
In-vitro Mutagenesis
13.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.7K
CRISPR
48.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.7K
Synthetic Biology
4.7K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
4.7K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K

